Journal
EUROPEAN JOURNAL OF CANCER
Volume 39, Issue 13, Pages 1828-1834Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0959-8049(03)00454-4
Keywords
mutant p53; cancer; small molecule; p53 reactivation; apoptosis; novel cancer therapy
Categories
Ask authors/readers for more resources
Around half of all human tumours carry mutant p53. This allows escape from p53-induced cell cycle arrest and apoptosis. Many tumours express mutant p53 proteins at elevated levels. Restoration of wild-type p53 function should trigger massive apoptosis in tumour cells and thus eradicate tumours. Various types of small molecules have been identified that can restore native conformation and wild-type function to mutant p53. Such molecules may serve as leads for the development of novel efficient anticancer drugs. (C) 2003 Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available